PHASE-II TRIAL OF DIAZIQUONE (AZQ) IN ADVANCED MALIGNANT-MELANOMA

被引：4
|
作者：
HOST, H
JOSS, R
PINEDO, H
BRUNTSCH, U
CAVALLI, F
RENARD, G
VANGIABBEKE, M
ROZENCWEIG, M
机构：
[1] DET NORSKE RADIUM HOSP,OSLO 3,NORWAY
[2] INSELSPITAL,INST MED ONKOL,CH-3010 BERN,SWITZERLAND
[3] FREE UNIV AMSTERDAM,ACAD ZIEKENHUIS,1081 HV AMSTERDAM,NETHERLANDS
[4] MED KLIN NURNBERG,NURNBERG KLIN,D-8500 NURNBERG,FED REP GER
[5] OSPED SAN GIOVANNI,SERV ONCOL,CH-6500 BELLINZONA,SWITZERLAND
[6] EUROPEAN ORG RES TREATMENT CANC,CTR DATA,B-1000 BRUSSELS,BELGIUM
[7] INST JULES BORDET,SERV MED,B-1000 BRUSSELS,BELGIUM
[8] INST JULES BORDET,HJ TAGNON INVEST CLIN LAB,B-1000 BRUSSELS,BELGIUM
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1983年 / 19卷 / 02期
关键词：
D O I：
10.1016/0277-5379(83)90430-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：295 / 298
页数：4
相关论文
共 50 条
  • [31] PHASE-II STUDY OF META-AMSA IN ADVANCED MALIGNANT-MELANOMA
    ARSENEAU, JC
    WOLTER, JM
    PROBERT, JC
    KUPERMINC, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04): : 433 - 436
  • [32] PHASE-II STUDY WITH ESORUBICIN (DXDX) IN ADVANCED MALIGNANT-MELANOMA (MMA)
    FRUSTACI, S
    GASPARINI, G
    GALLIGIONI, E
    TUMOLO, S
    FIGOLI, F
    MONFARDINI, S
    TUMORI JOURNAL, 1986, 72 (06): : 709 - 709
  • [33] POSITIVE PHASE-II STUDY IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA WITH FOTEMUSTINE
    SCHALLREUTER, KU
    WENZEL, E
    BRASSOW, FW
    BERGER, J
    BREITBART, EW
    TEICHMANN, W
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 29 (01) : 85 - 87
  • [34] PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
    BEDIKIAN, AY
    WEISS, GR
    LEGHA, SS
    BURRIS, HA
    ECKARDT, JR
    JENKINS, J
    ETON, O
    BUZAID, AC
    SMETZER, L
    VONHOFF, DD
    BENJAMIN, RS
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2895 - 2899
  • [35] RANDOMIZED PHASE-II TRIAL OF TCNU VERSUS MITOZOLOMIDE IN MALIGNANT-MELANOMA
    SMYTH, JF
    GUNDERSEN, S
    RENARD, J
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04): : 755 - 757
  • [36] PHASE-II TRIAL OF DIAZIQUONE IN ADVANCED OVARIAN-CARCINOMA
    LUND, B
    BRAMWELL, V
    RENARD, J
    HANSEN, HH
    DOMBERNOWSKY, P
    CANCER TREATMENT REPORTS, 1985, 69 (03): : 339 - 340
  • [37] AMINOGLUTETHIMIDE IN MALIGNANT-MELANOMA A PHASE-II STUDY
    BLOCK, S
    BONNETERRE, J
    ADENIS, A
    PION, JM
    DEMAILLE, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03): : 260 - 261
  • [38] N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THE EORTC MALIGNANT-MELANOMA COOPERATIVE GROUP
    KLEEBERG, UR
    MULDER, JH
    RUMKE, P
    THOMAS, D
    ROZENCWEIG, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (08): : 723 - 726
  • [39] PHASE-II EVALUATION OF DIAZIQUONE (CI-904, AZQ) IN THE TREATMENT OF HUMAN-MALIGNANT GLIOMA
    MARAL, J
    POISSON, M
    PERTUISET, BF
    MASHALY, P
    WEIL, M
    JACQUILLAT, C
    GRILLOLOPEZ, AJ
    JOURNAL OF NEURO-ONCOLOGY, 1985, 3 (03) : 245 - 249
  • [40] PHASE-II TRIAL OF DIAZIQUONE IN ADVANCED UPPER AERODIGESTIVE CANCER
    CREAGAN, ET
    LONG, HJ
    KVOLS, LK
    EDMONSON, JH
    OFALLON, JR
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 141 - 141
12345